PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 228 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $508,610 | +22.3% | 13,173 | +77.1% | 0.03% | +43.5% |
Q3 2021 | $416,000 | -34.7% | 7,437 | -29.1% | 0.02% | -32.4% |
Q2 2021 | $637,000 | -33.0% | 10,495 | -22.7% | 0.03% | -37.0% |
Q1 2021 | $951,000 | +47.7% | 13,575 | +26.1% | 0.05% | +17.4% |
Q4 2020 | $644,000 | -38.4% | 10,765 | -38.1% | 0.05% | +35.3% |
Q3 2020 | $1,046,000 | -75.9% | 17,397 | -79.0% | 0.03% | -69.6% |
Q2 2020 | $4,345,000 | -9.9% | 82,802 | -42.4% | 0.11% | -11.8% |
Q1 2020 | $4,822,000 | -34.1% | 143,824 | -11.0% | 0.13% | +23.3% |
Q4 2019 | $7,322,000 | +331.2% | 161,634 | +262.4% | 0.10% | +415.0% |
Q3 2019 | $1,698,000 | – | 44,595 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |